olprinone has been researched along with Heart Septal Defects, Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izumi, K; Jimi, N; Mizuno, K; Sakimura, S; Sumiyoshi, R; Yoshino, J | 1 |
| Kobayashi, T; Momoi, N; Sato, K; Sato, M; Sato, T; Suzuki, H | 1 |
2 other study(ies) available for olprinone and Heart Septal Defects, Ventricular
| Article | Year |
|---|---|
[Comparison of the effects of phosphodiesterase III inhibitors, milrinone and olprinone, in infant corrective cardiac surgery].
Topics: Cardiac Surgical Procedures; Female; Heart Septal Defects, Ventricular; Hemodynamics; Humans; Hypertension, Pulmonary; Imidazoles; Infant; Intraoperative Care; Male; Milrinone; Phosphodiesterase 3 Inhibitors; Pyridones; Retrospective Studies | 2013 |
Hemodynamic effects of phosphodiesterase III inhibitor in patients with a large ventricular left-to-right shunt.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cyclic Nucleotide Phosphodiesterases, Type 3; Heart Septal Defects, Ventricular; Hemodynamics; Humans; Imidazoles; Infant; Phosphodiesterase Inhibitors; Pyridones | 2000 |